Well, this certainly sums up that post nicely. LOL!
On the other hand, RXMD has plenty of facts at hand: * $20 million in 2017 revenues * Moved up to OTCQB * Stated goal of moving up to NASDAQ * Third-party-audited 2016 financials * Third-party auditing 2017 financials * Actively seeking M&A * Board directors with experience in M&A * Share price undervalued by several times
Facts! Accept no substitutes! :D
Please note: CAPS, BOLD, & DOUBLE-BOLD text are no substitute for facts, & fancy COLORS are no replacement for logic & a convincing argument.